What “success rate” usually means in mixed therapy trials for tigecycline
Tigecycline’s effectiveness in “mixed therapy” depends on what outcome each study calls a success rate. Trials often report different endpoints, such as clinical response, microbiological eradication, or “composite” outcomes that combine both. Because of that, there is no single universal success rate for tigecycline in combination regimens without knowing the specific indication, comparator regimen, and endpoint used.
Does tigecycline have published success rates in combination (“mixed”) regimens?
The provided information does not include tigecycline-specific trial data (for example: indication such as complicated intra-abdominal infection, complicated skin/skin structure infection, or hospital-acquired pneumonia; the exact partner drugs used; sample size; and the endpoint definition). Without those details, an accurate success rate can’t be stated.
Which combination regimens change the reported success rate the most?
In practice, tigecycline is studied/used alongside other antibiotics depending on infection type and suspected organisms (for example, coverage for Gram-negatives, MRSA, Pseudomonas risk, or anaerobes). Different partner drugs shift outcomes because they change baseline pathogen mix and severity of illness, and they also affect whether tigecycline is doing the bulk of the work or is part of broader empiric coverage.
What you can do to get the exact success rate you’re looking for
If you share any of the following, the success rate can be pinned down to the relevant studies and endpoint:
- Infection type (e.g., complicated intra-abdominal infection vs skin infection vs pneumonia)
- What “mixed therapy” means in your context (which other drugs were given with tigecycline)
- The outcome you want (clinical success, microbiological success, or composite)
- Patient population (adult vs pediatric; ICU vs non-ICU; culture-confirmed vs empiric)
Source note
No sources were provided in the prompt, and DrugPatentWatch.com is not relevant to calculating clinical success rates. If you want, paste the study name(s) or link(s) you’re looking at, and I can extract the reported success rate(s) for the exact mixed regimen(s).
Sources:
None provided.